Michael Prados

发表

Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility

Alexander R. Pico, Ivan Smirnov, Paul A. Decker, 2009, Nature Genetics.

A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium

Bo Zhang, Adam C Resnick, Sabine Mueller, 2019, International journal of cancer.

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Serban Nacu, Manfred Westphal, Zora Modrusan, 2010, Cancer cell.

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma

Anthony Asher, Susan Chang, Manfred Westphal, 2003, Journal of Neuro-Oncology.

Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma

Li Zhang, Susan Chang, Howard Colman, 2006, Clinical Cancer Research.

Central nervous system cancers: Clinical Practice Guidelines in Oncology.

Henry Brem, Alessandro Olivi, Deborah T Blumenthal, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.

Tom Mikkelsen, Randy Jensen, Patrick Y Wen, 2011, Neuro-oncology.

Central nervous system cancers.

Henry Brem, Alessandro Olivi, Mark R Gilbert, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma

Soonmee Cha, Susan M. Chang, M. Berger, 2009, Journal of Neuro-Oncology.

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

Albert Lai, Soonmee Cha, Rajan Jain, 2012, Journal of Neuro-Oncology.

Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.

Nancy J Fischbein, Tarik Tihan, Mitchel S Berger, 2005, AJNR. American journal of neuroradiology.

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

Susan Chang, Christoph Pedain, John Sampson, 2010, Neuro-oncology.

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.

Alona Muzikansky, Patrick Y Wen, M. Prados, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

Susan Chang, Frank Lieberman, Susan M. Chang, 2011, Journal of Neuro-Oncology.

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Koji Yoshimoto, Rameen Beroukhim, Paul S Mischel, 2005, The New England journal of medicine.

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Yan Li, Soonmee Cha, Susan M. Chang, 2016, Journal of Neuro-Oncology.

Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.

Gilbert Vezina, Tianni Zhou, Richard Sposto, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.